Total Payments
$3,304
2024 Payments
$233.85
Companies
40
Transactions
253
Medicare Patients
4,440
Medicare Billing
$433,329
Payment Breakdown by Category
Food & Beverage$3,304 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,304 | 253 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $837.77 | 85 | $0 (2024) |
| Novo Nordisk Inc | $282.22 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $252.76 | 14 | $0 (2020) |
| Allergan, Inc. | $199.92 | 17 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $192.94 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.57 | 12 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $132.21 | 8 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $112.26 | 9 | $0 (2019) |
| Amgen Inc. | $106.25 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.57 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.85 | 14 | AstraZeneca Pharmaceuticals LP ($40.27) |
| 2023 | $175.61 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($46.69) |
| 2022 | $64.86 | 5 | Lilly USA, LLC ($16.91) |
| 2021 | $151.14 | 8 | Bausch Health US, LLC ($39.56) |
| 2020 | $347.41 | 22 | PFIZER INC. ($42.17) |
| 2019 | $523.33 | 43 | PFIZER INC. ($121.33) |
| 2018 | $799.84 | 66 | PFIZER INC. ($299.73) |
| 2017 | $1,008 | 86 | PFIZER INC. ($274.44) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/09/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $5.88 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Bone Health | ||||||
| 07/01/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes Care | ||||||
| 05/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Gastroenterology | ||||||
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Gastroenterology | ||||||
| 06/12/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: VACCINES | ||||||
| 06/05/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINES | ||||||
| 05/08/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: SLEEP MEDICINE | ||||||
| 04/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Gastroenterology | ||||||
| 01/31/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,358 | 2,077 | $214,938 | $138,345 |
| 2022 | 19 | 966 | 1,537 | $155,695 | $98,185 |
| 2021 | 19 | 999 | 1,491 | $163,145 | $96,656 |
| 2020 | 25 | 1,117 | 1,743 | $177,859 | $100,143 |
Total Patients
4,440
Total Services
6,848
Medicare Billing
$433,329
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 778 | $101,140 | $61,490 | 60.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 199 | 199 | $27,860 | $24,041 | 86.3% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 29 | 85 | $16,825 | $10,689 | 63.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 42 | 50 | $12,500 | $9,683 | 77.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 15 | 77 | $8,795 | $6,092 | 69.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 102 | $9,180 | $6,059 | 66.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 185 | 185 | $3,700 | $3,090 | 83.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 178 | 178 | $3,560 | $2,975 | 83.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $8,800 | $2,755 | 31.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 41 | $3,485 | $2,180 | 62.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 24 | $3,480 | $1,967 | 56.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $2,800 | $1,769 | 63.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $2,700 | $1,710 | 63.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $2,750 | $662.20 | 24.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 15 | 16 | $720.00 | $648.80 | 90.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 20 | 24 | $1,752 | $611.20 | 34.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 16 | $1,280 | $543.76 | 42.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 44 | $1,056 | $357.00 | 33.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 31 | $790.00 | $257.28 | 32.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 12 | $300.00 | $194.64 | 64.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 37 | 37 | $370.00 | $182.88 | 49.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 53 | 71 | $695.00 | $156.20 | 22.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 22 | 22 | $220.00 | $134.42 | 61.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 18 | 18 | $180.00 | $96.22 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 628 | $81,640 | $49,631 | 60.8% |
About Dr. Brigitte King, MD
Dr. Brigitte King, MD is a Internal Medicine healthcare provider based in Mt Sterling, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780666305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brigitte King, MD has received a total of $3,304 in payments from pharmaceutical and medical device companies, with $233.85 received in 2024. These payments were reported across 253 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,304).
As a Medicare-enrolled provider, King has provided services to 4,440 Medicare beneficiaries, totaling 6,848 services with total Medicare billing of $433,329. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mt Sterling, KY
- Active Since 11/18/2005
- Last Updated 06/10/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780666305
Products in Payments
- CHANTIX (Drug) $333.59
- FARXIGA (Drug) $163.63
- VIAGRA (Drug) $122.63
- MYRBETRIQ (Drug) $108.43
- EVENITY (Biological) $106.25
- XIFAXAN (Drug) $99.81
- LYRICA (Drug) $97.06
- ENTRESTO (Drug) $95.14
- Tresiba (Drug) $90.24
- JANUVIA (Drug) $88.16
- Ozempic (Drug) $82.92
- TOUJEO (Drug) $74.48
- ANORO (Drug) $72.08
- ELIQUIS (Drug) $68.01
- TRULICITY (Drug) $65.69
- VRAYLAR (Drug) $61.57
- LINZESS (Drug) $55.96
- NAMZARIC (Drug) $53.92
- Myrbetriq (Drug) $53.04
- VESICARE (Drug) $52.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.